Yunngnin A



Compound IDCDAMM00673
Common nameYunngnin A
IUPAC name7-hydroxy-5,6-dimethoxy-2-oxochromene-8-carbaldehyde
Molecular formulaC12H10O6

Experimental data

Retention time3.36
Adduct[M+H]+
Actual mz251.054
Theoretical mz251.055
Error5.88
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.2485

Identifiers and class information

Inchi keyIVKYXTYKRIADDE-UHFFFAOYSA-N
SmilesO=CC1=C(O)C(OC)=C(OC)C=2C=CC(=O)OC12
SuperclassPhenylpropanoids and polyketides
ClassCoumarins and derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)4
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)250.207
Computed dipole moment(dipole)10.733
Total solvent accessible surface area (SASA)429.746
Hydrophobic component of SASA (FOSA)160.546
Hydrophilic component of SASA (FISA)172.751
Pie component of the SASA (PISA)96.45
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)735.604
Number of hydrogen bond donors (donorHB)0
Number of hydrogen bond acceptors (accptHB)5.75
Free energy of solvation of dipole (dip^2/V)0.156588
Index of cohesive interaction in solids (ACxDN^.5/SA)0
Globularity descriptor (glob)0.917028
Predicted polarizability in cubic angstroms (QPpolrz)21.638
Predicted hexadecane/gas partition coefficient (QPlogPC16)7.211
Predicted octanol/gas partition coefficient (QPlogPoct)12.148
Predicted water/gas partition coefficient (QPlogPw)7.366
Predicted octanol/water partition coefficient (QPlogPo/w)0.211
Predicted aqueous solubility (QPlogS)-0.699
Conformation-independent predicted aqueous solubility (CIQPlogS)-2.319
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-3.335
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)227.879
Predicted brain/blood partition coefficient (QPlogBB)-1.047
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)100.024
Predicted skin permeability, log Kp (QPlogKp)-3.979
PM3 calculated ionization potential (IP(ev))9.377
PM3 calculated electron affinity (EA(eV))1.229
Number of likely metabolic reactions (#metab)3
Prediction of binding to human serum albumin (QPlogKhsa)-0.955
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)70.381
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)109.172
Number of nitrogen and oxygen atoms (#NandO)6
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
O43570CA12Carbonic anhydrase XIIT16987SEA
Q16790CA9Carbonic anhydrase IXT64567SEA
P43166CA7Carbonic anhydrase VIIT37541SEA
P19838NFKB1Nuclear factor NF-kappa-B p105 subunitT83145SEA
Q08499PDE4DPhosphodiesterase 4DT02001SEA
O14980XPO1Exportin-1T51407SEA
Q16678CYP1B1Cytochrome P450 1B1T92521SEA
Q9HC98NEK6Serine/threonine-protein kinase NEK6T78992SEA
Q13332PTPRSReceptor-type tyrosine-protein phosphatase ST10147SEA
P02768ALBSerum albuminT63068SEA
P16220CREB1Cyclic AMP-responsive element-binding proteinT92098SEA
Q09470KCNA1Voltage-gated potassium channel Kv1.1T85272SEA
P22459KCNA4Voltage-gated A-type potassium channelT15665SEA
P16389KCNA2Voltage-gated potassium channel Kv1.2T19492SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16987DI0046Bacterial infection[ICD-11: 1A00-1C4Z]O43570CA12
T16987DI0372Seborrhoeic dermatitis[ICD-11: EA81]O43570CA12
T64567DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q16790CA9
T83145DI0218Irritable bowel syndrome[ICD-11: DD91]P19838NFKB1
T83145DI0366Rheumatoid arthritis[ICD-11: FA20]P19838NFKB1
T02001DI0411Tonus and reflex abnormality[ICD-11: MB47]Q08499PDE4D
T51407DI0234Liposarcoma[ICD-11: 2B59]O14980XPO1
T51407DI0274Multiple myeloma[ICD-11: 2A83]O14980XPO1
T51407DI0395Stomach cancer[ICD-11: 2B72]O14980XPO1
T10147DI0057Bone paget disease[ICD-11: FB85]Q13332PTPRS
T63068DI0029Aneurysm/dissection[ICD-11: BD50]P02768ALB
T63068DI0059Bowel habit change[ICD-11: ME05]P02768ALB
T63068DI0077Cholelithiasis[ICD-11: DC11]P02768ALB
T63068DI0202Inborn energy metabolism error[ICD-11: 5C53]P02768ALB
T63068DI0218Irritable bowel syndrome[ICD-11: DD91]P02768ALB
T63068DI0343Preprocedural examination[ICD-11: QA0B]P02768ALB
T63068DI0366Rheumatoid arthritis[ICD-11: FA20]P02768ALB
T63068DI0370Schizophrenia[ICD-11: 6A20]P02768ALB
T63068DI0420Unspecific body region injury[ICD-11: ND56]P02768ALB

Copyright © 2025